Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture
about
Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapyAbsence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected miceFamciclovir for treatment of herpesvirus infectionsIn vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virusMode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cellsSelection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]Activities of two new antiviral agents against guinea pig lymphotropic herpesvirus infection in vitroAntiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animalsActivity of penciclovir against Epstein-Barr virusMode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.Evaluation of a novel, anti-herpes simplex virus compound, acyclovir elaidate (P-4010), in the female guinea pig model of genital herpesAntiherpesvirus activities of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) in cell cultureFamciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study.Determination of penciclovir in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study.Intravenous penciclovir for treatment of herpes simplex infections in immunocompromised patients: results of a multicenter, acyclovir-controlled trial. The Penciclovir Immunocompromised Study Group.Emerging drugs for varicella-zoster virus infections.Novel agents for the therapy of varicella-zoster virus infections.Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines.9-[4-Hydr-oxy-3-(hydroxy-meth-yl)but-yl]guanine monohydrateActivity and mechanism of action of N-methanocarbathymidine against herpesvirus and orthopoxvirus infections.The tolerance to and pharmacokinetics of penciclovir (BRL 39,123A), a novel antiherpes agent, administered by intravenous infusion to healthy subjects.Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapyComparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.A review of famciclovir in the management of genital herpes.Effects of probenecid on the pharmacokinetics of allopurinol riboside.New antiviral agents.Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacologyA review of antiviral drugs and other compounds with activity against feline herpesvirus type 1Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): DNA viruses.Management of genital herpes simplex infection.The resurgence of acyclic nucleic acids.5-azacytosine compounds in medicinal chemistry: current stage and future perspectives.Difference in incidence of spontaneous mutations between Herpes simplex virus types 1 and 2.Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.Synthesis of novel 6-azapyrimidine acyclic nucleoside analogues and antiviral evaluation.In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS.Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile (2nd edition): retroviruses and hepadnaviruses.
P2860
Q24672068-0EBC76B5-76AD-4B11-9C37-CDFF7E4FA11BQ24797196-E11DE36F-4162-4924-AA43-280DEA73E5B8Q28293932-129E2C46-547B-45D7-ABE1-ECE97ECA7915Q28326891-34F7329F-7836-4418-ABC7-095632B8FB17Q28327167-D1FCC5B2-2234-4CAE-8AE1-B801451D672DQ28342540-B8EDE62D-3320-4E46-8764-FC8FD9FCD901Q28354274-D6D42013-1508-4D15-BCD4-836C9DCBDB1CQ28359733-D5BF0DA6-D828-45D2-BE81-37D1D0029C39Q28361450-AA446783-A112-4225-8123-CEFBB31324F5Q28367461-99CFD752-65B5-4922-942E-C0F49AD8BB24Q28368325-6B563FD9-4C4B-4589-A8F4-AC71A532775EQ28369457-FFD795AC-58B7-4523-94D6-C64D285819ABQ28379618-DA3E75F2-011A-4D62-920C-A61557D65709Q33693860-DE7CB9DE-2652-4899-B509-621B434FAAEFQ33837094-3237BA2D-94CE-4409-9707-EBD8BA33ED54Q33976296-1A0377EF-52E2-464C-A941-EA2BA3879EE7Q34027426-5FB2C529-74C6-4230-A364-90869552DEB6Q34074994-177DE24A-4473-4EBE-B22F-07DB1506E1CCQ34113580-BF827C90-E172-47D4-931F-2829192C4BADQ34270723-5B3B31D3-814F-48FB-8C31-D7F350E62223Q34510424-6A24F569-7E48-4BD0-808F-224D9608CAD1Q34538195-6FDE09AC-8A19-4F3B-9D5B-79EC275B973BQ34579981-872405A4-C0E3-4AB0-A3ED-D29A998320D9Q34729783-7351B85C-FC12-4A31-94DD-7AC3A1209CF1Q35615364-D39978C4-01B9-488E-AF02-66A13FA0F39BQ35815511-892CB71C-38AD-41C5-AE9E-5156E3E7CD68Q36525651-9DCF9294-978B-4328-82D6-C2BF55FBD962Q36688916-60C3F911-27DB-45EB-9605-CF881CA47F62Q36823598-19D9C9C5-7025-4C27-A76F-6920CC24192EQ37059841-0AB10878-AB45-436E-8676-2D6874BAA771Q37252268-5E03E792-9B2B-4A52-A832-E6B3F04D030DQ37545127-1E0D6CF8-3D7C-438B-AC6B-DB99E5B76F66Q37691376-CE417A8C-401E-4CCE-95ED-41E2B9EFC8A0Q38014898-0A33A0C6-3E70-4DA8-B6B0-F8F6ADEF0D64Q39474039-9D71266A-9CDB-40BB-926A-D187F00EA259Q39602136-B987F252-EA43-4A03-B686-5F663D623607Q39686917-F99FDD68-B2D3-43B3-83C0-E4CBC220CDE6Q39882007-02E044DA-9B69-4796-8917-902F1D05DC48Q40044028-171C5A88-1054-4562-A840-C95397D77EFBQ40055204-C3B76CB3-22C5-46BA-87D3-A6D56BCAE7B0
P2860
Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture
description
1987 nî lūn-bûn
@nan
1987 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture
@ast
Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture
@en
Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture
@nl
type
label
Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture
@ast
Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture
@en
Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture
@nl
prefLabel
Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture
@ast
Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture
@en
Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture
@nl
P2093
P2860
P356
P1476
Antiherpesvirus activity of 9- ...... ne (BRL 39123) in cell culture
@en
P2093
P2860
P304
P356
10.1128/AAC.31.8.1238
P407
P577
1987-08-01T00:00:00Z